SCHEMBL8851189

SCHEMBL8851189

CCN(CCCN)C1CC[N]CC1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8851913 0.89
SCHEMBL8851207 0.87 DRD3 (0.36)
SCHEMBL6973232 0.86 MEN1 (0.37) GRIN2BMEN1KMT2A
SCHEMBL10863566 0.82 ADH1A (0.35) GRIN2BMEN1KMT2A
SCHEMBL8852108 0.81 CHRM1 (0.34) GRIN2B
SCHEMBL8851201 0.81 SIGMAR1 (0.32) GRIN2B
SCHEMBL6974292 0.80 CHRM2 (0.39) GRIN2BMEN1KMT2A
SCHEMBL293248 0.80
SCHEMBL8852338 0.79 DRD3 (0.32)
SCHEMBL8851216 0.79 SIGMAR1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5618814-A Trisubstituted pyrimido [5,4-d] pyrimidines for modulating multi-drug resistance and pharmaceutical compositions containing these compounds DR. KARL THOMAE GMBH (DE) 1997-04-08 US disclosed
EP-0645390-A1 Trisubstituted pyrimido 5,4-d pyrimidines for modulating multidrug resistance, drugs containing these compounds and processes for their preparation Dr. Karl Thomae GmbH (DE) 1995-03-29 EP disclosed